Sildenafil vs tadalafil is mainly a choice between on-demand timing and a longer, more flexible treatment window. A 2026 network meta-analysis found greater efficacy with on-demand sildenafil, while tadalafil had the lowest odds of treatment-related adverse events.1 Tadalafil is also the only one of the two with a once-daily erectile dysfunction regimen in its US prescribing information; the sildenafil label covers on-demand use only.2,4 Neither drug wins every comparison. Your medication list, routine, food timing, prostate symptoms, and underlying cause should guide the prescription.
The Clinical Differences Between the Two Drugs
Sildenafil and tadalafil are phosphodiesterase type 5 (PDE5) inhibitors used to improve erectile function.3 They limit the breakdown of a signaling molecule that helps blood vessels relax during sexual stimulation. The full mechanism is explained in our guide to PDE5 inhibitors.
The main differences involve food, timing, approved dosing patterns, and other conditions covered by the label. Tadalafil offers on-demand and once-daily treatment. Sildenafil is used on demand.
The FDA labels report the time required to reach maximum plasma concentration. That measurement is useful for comparing absorption, but it does not guarantee when you will notice an effect.
| Drug | Duration of Action | Time to Onset (Median) | Effect of Food | Dosing Patterns the Label Approves | Adverse-Event Odds Ranking vs Placebo | Also Approved For |
|---|---|---|---|---|---|---|
| Sildenafil | The label reports terminal half-lives of about 4 hours. See how long sildenafil lasts for the duration details.4 | The label does not provide a median clinical onset. Maximum plasma concentration occurs within 30 to 120 minutes, with a median of 60 minutes when fasted.4 | A high-fat meal delays absorption by a mean of 60 minutes and reduces the maximum concentration by a mean of 29%.4 | On-demand use.4 | Below vardenafil and avanafil, but above tadalafil in the 2026 network ranking.1 | Erectile dysfunction.4 |
| Tadalafil | The label reports improved erectile function for up to 36 hours after a dose.2 | The label does not provide a median clinical onset. Maximum plasma concentration occurs between 30 minutes and 6 hours, with a median of 2 hours.2 | Food does not affect the rate or extent of absorption.2 | On-demand or once-daily use for erectile dysfunction.2 | Lowest odds of treatment-related adverse events among the drugs included in the 2026 analysis.1 | Erectile dysfunction and benign prostatic hyperplasia (BPH).2 |
The choice often comes down to your week. Sildenafil may fit planned use when the meal and dose can be coordinated. Tadalafil may fit a less scheduled routine or a treatment plan that also needs to address BPH.
The approved regimens and adverse-event rankings come from labels and trial populations. Your physician reads those numbers against your medication list, health history, and routine.
The Evidence Behind Sildenafil vs Tadalafil
In the most recent network meta-analysis of on-demand dosing, sildenafil showed the greatest efficacy.1 The 2026 network meta-analysis included 83 double-blind, placebo-controlled randomized studies and 6,029 participants. It defined satisfactory erectile function as an International Index of Erectile Function domain score above 26.
In that analysis, sildenafil 100 mg had an odds ratio of 9.06 versus placebo, while sildenafil 50 mg had an odds ratio of 7.90. Tadalafil 20 mg had an odds ratio of 7.13, and tadalafil 10 mg had an odds ratio of 3.14.1 These figures describe doses evaluated in the included trials. They are not dosing recommendations.
Each odds ratio compares a drug and dose with placebo within the network. The study did not conduct a single direct head-to-head trial between every listed dose. The odds ratios also do not create a conversion formula between sildenafil and tadalafil.
The authors concluded that sildenafil had statistically greater efficacy than the other PDE5 inhibitors included in the analysis.1 They also reported wide confidence intervals in some comparisons, which increased uncertainty around those estimates. Sildenafil led the efficacy ranking, while tadalafil had the lowest odds of treatment-related adverse events.
That distinction should shape your decision. Bring your schedule, your medication list, and your treatment goals to the consultation; those are what turn an average ranking into the right prescription for you.
Daily and On-Demand Treatment Patterns
Tadalafil is the only one of these two drugs with an FDA-approved once-daily erectile dysfunction regimen.2,4 Its label also allows on-demand use. Sildenafil is labeled for on-demand use.4
The tadalafil label names a lower recommended starting dose for once-daily erectile dysfunction treatment than for as-needed use, and your prescriber sets which regimen applies to you.2 Starting-dose language does not account for the cause of erectile dysfunction or your full medication list. Follow-up gives your prescriber a real response to read before the plan changes. These are descriptions of approved label regimens. Your prescriber sets your dose after reviewing efficacy, tolerability, health conditions, and other medications.
The 2026 network meta-analysis evaluated on-demand dosing.1 Its efficacy ranking cannot be extended to once-daily tadalafil because that regimen was outside the study objective. Any efficacy claim you see about daily tadalafil is borrowing evidence collected under a different treatment pattern.1
If daily treatment or BPH is part of your clinical goal, tadalafil gains an approved use that sildenafil does not carry. If your physician is comparing on-demand efficacy alone, the recent network evidence favors sildenafil. Name which of the two decisions you are actually making when you raise this with your physician, and the comparison stops being a tie.
Tadalafil vs Sildenafil Side Effects and Medication Safety
Tadalafil had the lowest odds of treatment-related adverse events in the 2026 network meta-analysis.1 Sildenafil ranked below vardenafil and avanafil, but above tadalafil. This was a ranking against placebo. It was not a percentage side-effect rate, and it does not establish that tadalafil is safer for every person.
Your medication list can override the average ranking. The FDA labels for Viagra and Cialis contraindicate use with nitrates because the combination can lower blood pressure.2,4 If you use nitrates in any form, both drugs are excluded by their labels. Your physician will need to consider another treatment pathway.
Both labels also include precautions for alpha-blocker therapy. Patients taking an alpha-blocker should be stable on that treatment before either drug is started, and each label sets a reduced starting dose for that situation.2,4 This medication review belongs before the prescription.
A low adverse-event ranking cannot account for every medication interaction or existing condition. Your physician should read the label precautions against your full medical history before choosing either drug.
The Clinical Inputs Behind the Prescription
A physician should match the prescription to your routine, health history, and treatment goals. The efficacy ranking is one input. It does not replace a medication review or an erectile dysfunction evaluation.
Food timing may affect the choice. A high-fat meal delays sildenafil absorption, while food does not affect tadalafil absorption.2,4 If meals and timing are difficult to coordinate, that difference can influence how well the prescription fits your routine.
Frequency also changes the decision. On-demand treatment may suit occasional or planned use. A once-daily tadalafil regimen removes the need to coordinate each dose with anticipated sexual activity, but the prescription still requires clinical review and ongoing assessment.2
BPH symptoms provide another reason to consider tadalafil because its label covers both erectile dysfunction and BPH.2 Sildenafil does not carry that additional indication in the cited label.4 If BPH is part of your history, raise it during the prescribing consultation.
The American Urological Association (AUA) guideline supports evaluating erectile dysfunction before treatment and recognizes PDE5 inhibitors as a first-line option.5 That evaluation can change the prescription when erectile dysfunction appears alongside cardiovascular, metabolic, hormonal, or medication-related concerns.
Price is another practical input, but it is separate from clinical efficacy. Review the medication and monitoring line items in our guide to erectile dysfunction medication cost before comparing the total expense.
The Underlying Causes Worth Testing For
Sildenafil and tadalafil improve erectile function without identifying why erectile dysfunction began.3,5 Erectile dysfunction can warrant a broader review of vascular health, metabolic function, hormones, medications, and symptoms. The next step is a clinical workup when the cause has not been assessed.
One isolated lab value rarely provides the full answer. Your physician needs to compare related biomarkers with your symptoms, medication list, and changes over time. That pattern can show whether the prescription belongs inside a broader treatment plan.
Our guide to erectile dysfunction causes explains the clinical drivers that may require evaluation. If you are comparing prescription treatment with supplements, review the evidence for natural PDE5 inhibitors, and the separate trial record for L-citrulline, before spending money on an unproven substitute.
The Opt Take on Sildenafil vs Tadalafil
Opt Health treats the prescription as one part of a physician-led care loop. Your physician uses your labs, other medications, and daily routine to choose between sildenafil and tadalafil. Follow-up shows whether the treatment plan needs adjustment. We begin with 55+ biomarkers, and a physician reads the results against your symptoms, medications, routine, and goals. The physician then builds a plan and adjusts it as your results change.
Full labs and a physician consultation repeat every 3 to 4 months. This follow-up gives your physician a trend instead of a single result. It also creates a set time to review response, side effects, and changes in your health.
A testosterone result alone is a data point. Hormonal, metabolic, inflammatory, and cardiovascular markers can form a pattern when read together. Your treatment plan follows the pattern.
Your next sildenafil vs tadalafil review should include your complete medication list, prostate symptoms, treatment frequency, and any labs related to the underlying cause.
Get started: Begin with Opt Health, where a physician reads your labs, builds your plan, and adjusts it over the loop.
Frequently Asked Questions
No evidence in the cited comparison shows that tadalafil produces a harder erection than sildenafil. The 2026 analysis measured the proportion of participants who reached satisfactory erectile function on a validated questionnaire. Sildenafil led the efficacy ranking for on-demand use, while tadalafil had the lowest odds of treatment-related adverse events.1
No approved erectile dysfunction pill has been shown to work 10 times better than Viagra. The 2026 analysis included sildenafil, tadalafil, vardenafil, and avanafil, and it did not identify any drug with an order-of-magnitude advantage over sildenafil.1
If response is inadequate, your physician can review whether the prescribed regimen has been optimized and whether a vascular, metabolic, hormonal, or medication-related cause has been missed. A supplement should not be treated as a stronger substitute without supporting clinical evidence.
The 2026 analysis placed sildenafil first in its overall efficacy conclusion, followed by tadalafil and vardenafil.1 Avanafil was also included. The analysis covered on-demand dosing and used satisfactory erectile function as its primary outcome.
That ordering is not a prescription ranking for every person. Tadalafil led the adverse-event comparison, while your medications, BPH symptoms, and preferred dosing pattern may support a different choice.
No. Both are doses their labels list, but there is no published bioequivalence between them in the approved sources.2,4 The odds ratios from the network meta-analysis also cannot be used as a conversion table. Your prescriber should choose each drug and dose on its own label, expected response, and tolerability.
Sildenafil may be the better on-demand choice when your physician prioritizes the efficacy findings from the 2026 network meta-analysis.1 Tadalafil may fit better when you want an approved once-daily regimen, need a wider treatment window, have BPH, or prefer a drug unaffected by food.2
Neither option is appropriate if you use nitrates.2,4 Your physician should review alpha-blockers, other medications, and the cause of erectile dysfunction before prescribing either drug.
The tadalafil label names a recommended starting dose for as-needed use in most patients, and a lower one for once-daily use.2 That label statement cannot predict whether the dose will provide a satisfactory response for you. Your prescriber assesses efficacy and tolerability and decides whether another labeled regimen is appropriate.
Choosing between sildenafil and tadalafil takes a review of your medication list, health history, labs, and routine. An Opt Health membership pairs comprehensive labs with a physician who builds your treatment plan and adjusts it during follow-up.
References
- Salonia A, et al. A comparative evaluation of on-demand phosphodiesterase-5 inhibitor efficacy in erectile dysfunction treatment: a systematic review and network meta-analysis of double-blind, placebo-controlled, randomized trials. J Sex Med. 2026;23(7):qdag176. https://pubmed.ncbi.nlm.nih.gov/42296271/
- Eli Lilly and Company. CIALIS (tadalafil) tablets, US prescribing information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bcd8f8ab-81a2-4891-83db-24a0b0e25895
- Pyrgidis N, et al. The effect of phosphodiesterase-type 5 inhibitors on erectile function: an overview of systematic reviews. Front Pharmacol. 2021;12:735708. https://pubmed.ncbi.nlm.nih.gov/34557099/
- Pfizer Laboratories Div Pfizer Inc. VIAGRA (sildenafil citrate) tablets, US prescribing information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0b0be196-0c62-461c-94f4-9a35339b4501
- Burnett AL, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29746858/
```membership_cta Choosing between sildenafil and tadalafil takes a review of your medication list, health history, labs, and routine. An Opt Health membership pairs comprehensive labs with a physician who builds your treatment plan and adjusts it during follow-up. ```
This content is for informational purposes and does not replace evaluation, diagnosis, or treatment by a qualified medical professional.
Start Today
Your health, your terms. Discover how personalized care can transform not just the way you feel, but how you live.